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Desmin is a type III intermediate ﬁlament (IF) component protein expressed speciﬁcally in muscular
cells. Desmin is phosphorylated by Aurora-B and Rho-kinase speciﬁcally at the cleavage furrow from
anaphase to telophase. The disturbance of this phosphorylation results in the formation of unusual long
bridge-like IF structures (IF-bridge) between two post-mitotic (daughter) cells. Here, we report that
desmin also serves as an excellent substrate for the other type of mitotic kinase, Cdk1. Desmin phos-
phorylation by Cdk1 loses its ability to form IFs in vitro. We have identiﬁed Ser6, Ser27, and Ser31 on
murine desmin as phosphorylation sites for Cdk1. Using a site- and phosphorylation-state-speciﬁc
antibody for Ser31 on desmin, we have demonstrated that Cdk1 phosphorylates desmin in entire
cytoplasm from prometaphase to metaphase. Desmin mutations at Cdk1 sites exhibit IF-bridge pheno-
type, the frequency of which is signiﬁcantly increased by the addition of Aurora-B and Rho-kinase site
mutations to Cdk1 site mutations. In addition, Cdk1-induced desmin phosphorylation is detected in
mitotic muscular cells of murine embryonic/newborn muscles and human rhabdomyosarcoma speci-
mens. Therefore, Cdk1-induced desmin phosphorylation is required for efﬁcient separation of desmin-IFs
and generally detected in muscular mitotic cells in vivo.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Intermediate ﬁlaments (IFs), together with microtubules and
actin ﬁlaments, form the cytoskeletal framework in the cytoplasm
of virtually all vertebrates. IF component proteins are divided intoy, Mie University School of
ichi Cancer Center Research
agaki@doc.medic.mie-u.ac.jp
r Inc. This is an open access articlesix groups and their composition depends on tissue type and dif-
ferentiation step [1e3]. Vimentin, a type III IF protein conserved in
vertebrate evolution, is expressed in all mesenchymal cells [4,5]. On
the other hand, glial ﬁbrillary acidic protein (GFAP) and desmin,
different type III IF proteins, are expressed speciﬁcally in astroglial
and muscular cells, respectively [6e8].
Accumulating evidence has suggested that IF disassembly is
regulated by phosphorylation of Ser/Thr residues in the amino-
terminal head domain on IF proteins [9,10]. Site- and phosphory-
lation state-speciﬁc antibodies that can recognize a phosphorylated
residue and its ﬂanking sequence [11,12] are powerful tools to
demonstrate site (domain)-speciﬁc IF phosphorylation in cells
[13e15]. Using such antibodies for 4 distinct phosphorylation sitesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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phorylated by at least 2 types of protein kinases [12,16e18]. Cdk1
phosphorylates Ser8 on GFAP from prometaphase to metaphase.
This phosphorylation is detected on glial ﬁlaments in the entire
cytoplasm. The other type phosphorylates Thr7, Ser13, and Ser38
on GFAP during anaphase and telophase. The phosphorylation of
the above 3 sites is restricted to the cleavage furrow both beneath
the plasma membrane and outside the spindle midzone. Further
detailed studies revealed that 2 distinct protein kinases participate
in this cleavage-furrow-speciﬁc GFAP phosphorylation [18e20].
One is Rho-associated kinase (Rho-kinase; also called ROK or
ROCK), a kinase activated just beneath the plasmamembrane in the
cleavage furrow [19]. The other is Aurora B, a kinase activated in the
spindle midzone/midbody [20]. By transient expression of GFAP
mutated at these mitotic phosphorylation sites to Ala in type III IF-
deﬁcient T24 cell line, we found that the disturbance of cleavage-
furrow-speciﬁc GFAP phosphorylation induced abnormal IF struc-
ture connecting two daughter cells (referred as IF-bridge) during
the cytokinetic process, whereas GFAP mutation at a Cdk1 site
(Ser8) did not exhibit the IF-bridge phenotype [21].
These two types of mitotic IF phosphorylation is conserved in
vimentin [22e24], whereas additional protein kinases including
protein kinase C (PKC) and Polo-like kinase 1 (Plk1) also participate
in mitotic vimentin phosphorylation [25,26]. Like GFAP case,
cleavage-furrow-speciﬁc vimentin phosphorylation by Rho-kinase
and Aurora-B is critical for efﬁcient segregation of vimentin-IFs in
mitotic processes [24,27], whereas vimentin phosphorylation by
other protein kinases (such as Cdk1) also contributes to mitotic
separation of vimentin-IFs [26,27].
Desmin is phosphorylated at Thr16, Thr75, and Thr76 by Rho-
kinase [28] and at Ser11, Thr16, and Ser59 by Aurora-B [20] (also
see Fig. 1D). Desmin phosphorylation by Rho-kinase [29] and
Aurora-B [20] is also detected speciﬁcally at cleavage furrow and
required for efﬁcient separation of desmin-IFs in mitosis [20]. We
also reported that desmin is phosphorylated by Cdk1 in vitro [30],
but the signiﬁcance of this phosphorylation in vivo remains largely
unknown. Here, we report that Cdk1-induced desmin phosphory-
lation contributes to efﬁcient separation of desmin-IFs during
mitotic processes, together with cleavage-furrow-speciﬁc desmin
phosphorylation by Rho-kinase and Aurora-B. In addition, this
phosphorylation is generally detected in mitotic muscular cells
in vivo.
2. Materials and methods
2.1. Antibodies
Rabbit polyclonal anti-desmin-phsophoSer59 (PD59) [20] and
-phosphoThr75 (PD75) [29] antibodies were produced and puriﬁed
as described. Rat monoclonal anti-desmin-phosphoSer31 (clone
name TD31) was produced as described previously [11,15,31].
Commercial sources were as follows: mouse anti-GFAP (clone GA5;
Cell Signaling Technology, Beverly, MA, USA), pan-keratin (SIGMA-
Aldrich, St Louis, MO, USA), rabbit anti-desmin (clone Y66 [Abcam,
Cambridge, MA, USA] or clone D93F5 [Cell Signaling Technology]),
guinea pig anti-vimentin (Progen Biotechnik, Heidelberg, Ger-
many), and goat anti-b-actin (Santa Cruz Biotechnology, Santa Cruz,
CA, USA).
2.2. Preparation of proteins
Mouse desmin with a C-terminal His-tag was expressed in
Escherichia coli BL21-CodonPlus (DE3)-RIPL (Agilent Technologies,
Palo Alto, CA, USA) and then puriﬁed from inclusion bodies through
nickel-afﬁnity chromatography according to manufacturer'sprotocols (Qiagen, Chatsworth, CA, USA). No-tagged recombinant
human desmin was prepared from E. coli as described previously
[28]. GST-cyclin B and Cdk1 complex, GST-Rho-kinase-catalytic-
domain (a constitutively active mutant) [23], or GST-Aurora B/
His-INCENP-IN-Box was expressed in baculovirus-infected Sf9 cells
and puriﬁed through glutathione-Sepharose beads according to
manufacturer's protocols (Life Technologies, Carlsbad, CA, USA).
2.3. Phosphorylation of desmin
Desmin was incubated at 25 C in the reaction mixture (25 mM
Tris-Cl [pH 7.5], 100 mM ATP, and 100e200 mg/ml desmin) con-
taining 1.5, 0.15, or 2 mM MgCl2 in the presence of 40 mg/ml GST-
cyclin B1/Cdk1, 100 mg/ml GST-Rho-kinase-catalytic-domain, or
2 mg/ml GST-Aurora B/His-INCENP-IN-Box, respectively. Some re-
actions were performed in the presence of [g-32P]ATP.
2.4. Analyses on IF-bridge formation
Type III-IF-negative T24 cells stably expressing EBNA-1 were
established as described previously [21]. Before seeding, dishes and
coverslips were coated with PureCol collagen (1:30e60 diluted
with sterile water; Advanced BioMatrix, San Diego, CA, USA) for 2 h
and then washed twice with phosphate-buffered saline (PBS). The
above T24 cells were seeded on the collagen-coated dishes. 9 h after
seeding, the cells were transfected with pDR2 vector (BD Clontech,
Palo Alto, CA, USA) carrying each type of murine desmin in the
presence of Lipofectamine LTX and Plus™ reagent (Thermo Fisher
Scientiﬁc, San Jose, CA, USA). In order to analyze IF-bridge pheno-
type effectively, we performed the following procedures. 24 h after
transfection, 50 ng/ml nocodazole was added in the growing me-
dium to arrest cells in early mitosis. After 4-h-incubation with
nocodazole, mitotic T24 cells were collected by pipetting off the
supernatant medium. This mitotic cell suspension was centrifuged
at 1000g for 10min to remove nocodazole-containing medium. The
resulting cell pellets were washed with PBS twice, re-suspended
with the growing medium, and then re-seeded on collagen-
coated coverslips. These cells were incubated for an additional
20 h and then subjected to immunocytochemistry with anti-
desmin to analyze IF-bridge phenotype.
2.5. Immunohistochemistry and immunoﬂuorescence
Tissue sections from two patients with rhabdomyosarcoma at
different primary sites (14 years-old [yo] male, upper arm; 4 yo
male, lower leg) were obtained with informed patient consent at
the Nagoya University Hospital. For immunohistochemistry studies,
formaldehyde-ﬁxed, parafﬁn-embedded tumor tissue sections and
mouse tissues (embryonal day 15.5, postnatal day 0 and 28) were
deparafﬁnized, and antigens were retrieved by boiling samples in
target retrieval solution at pH 9 (Dako, Carpinteria, CA, USA) for
30 min. Subsequently, tissue sections were washed with PBS,
blocked with blocking reagent (Dako), and incubated overnight at
4 Cwith TD31 (dilution 1:1000) and anti-desmin (dilution 1:2000;
Abcam) antibodies diluted in antibody diluents (Dako). Tissue
sections were then washed, treated with 5% hydrogen peroxide/
ethanol solution for 15 min at room temperature (RT), and incu-
bated at RT for 30 min with horseradish peroxidase (HRP)-conju-
gated anti-rat or anti-mouse IgG secondary antibodies (EnVision
System, Dako), followed by signal detectionwith diaminobenzidine
(DAB) solution.
For immunoﬂuorescence, tissue sections were incubated over-
night at 4 C with primary antibodies diluted in antibody diluents
(Dako). Sections were then washed with PBS and incubated at RT
for 1 h in PBS containing Alexa Fluor 488/594-conjugated
Fig. 1. Desmin phosphorylation by Cdk1. (A) Time course of phosphorylation of murine desmin by Cdk1. (B) Soluble human desmin was pre-incubated with (þ) or without () Cdk1
for 1 h. The samples were incubated at 37 C in the buffer containing 50 mM NaCl for an additional 1 h and then subjected to high speed centrifugation (10,000g for 30 min at 25 C)
in order to separate soluble (supernatant; S) and insoluble (pellet; P) fractions. These fractions were subjected to SDS-PAGE, and the gel was stained with Coomassie Brilliant Blue
(CBB). (C) Murine desmin wild-type (WT) or its mutant in which the indicated site is changed to Ala was incubated with Cdk1 for 5 min 3A indicates desmin mutated at Ser6, Ser27,
and Ser31. (D) Summary of desmin phosphorylation sites by each mitotic kinase. (E) Murine desmin WT was incubated with or without each mitotic kinase. (F) Whole cell lysates of
each cell line were subjected to the immunoblotting with the indicated antibodies. (G) Cells were arrested in early mitosis by addition of 50 ng/ml nocodazole for 4 h. Interphase (I)
or mitotic (M) cells were collected as described previously [23]. (H) Each cell line was stained with TD31 and DAPI (red; pseudo-color). (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
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mounted with PermaFluor (Thermo Fisher Scientiﬁc), and ﬂuores-
cence was examined using a confocal laser-scanning microscope
(LSM 700, Carl Zeiss, Oberkochen, Germany). This study was
approved by the Ethics Committee of Nagoya University Graduate
School of Medicine.3. Results and discussion
We previously reported that Cdk1 can phosphorylate desmin
puriﬁed from chicken muscular tissues [30]. Similar to this report
[30], GST-cyclin B1/Cdk1 complex (referred to as Cdk1) phosphor-
ylated murine desmin in a time-dependent manner: the level of
phosphorylation was approximately 2 mol of phosphate/mol of
desmin at 2 h (Fig. 1A). Next, we examined the effect of Cdk1-
induced desmin phosphorylation on its ﬁlament forming ability.
Soluble human desmin was pre-incubated with (þ) or without ()
Cdk1 for 1 h and then incubated under the polymerization condi-
tion for an additional 1 h. After high speed centrifugation (10,000g),
supernatant (S) and pellet (P) fractions were subjected to SDS-
PAGE. As shown in Fig. 1B, the majority of desmin incubated
without Cdk1 was fractionated into the insoluble fraction (P),
indicating that desmin was likely polymerized under this experi-
mental condition. On the other hand, the incubation with Cdk1
dramatically increased desmin solubility. These results conﬁrmedour previous report that desmin phosphorylation by Cdk1 induced
the disassembly of desmin-IFs in vitro [30].
We previously reported that Cdk1 can phosphorylate Ser6,
Ser22, and Thr64 on chicken desmin [30]. According to a public
database PhosphoSitePlus® (http://www.phosphosite.org), Ser6
and Ser22 on chicken desmin are corresponding to Ser6 and Ser31
on murine desmin, respectively; the ﬁrst Met is uncounted in each
amino acid position. However, Thr64 prior to Pro is not conserved
in murine desmin, but Ser27 on murine desmin is located prior to
Pro. Therefore, we produced murine desmin in which Ser6, Ser27,
and/or Ser31 were changed to Ala. As shown in Fig. 1C, each mu-
tation reduced 32P-incorporation into murine desmin by Cdk1. The
triple mutations almost diminished the 32P-incorporation, sug-
gesting that Ser6, Ser27, and Ser31 on murine desmin were phos-
phorylation sites for Cdk1 (Fig. 1C and D).
Ser6 and Ser31 on desmin are conserved among human, mouse,
rat, dog, and chicken. In addition, Ser31 is one of two major phos-
phorylation sites (Fig. 1C). Thus, we produced a site- and
phosphorylation-state-speciﬁc antibody for Ser31 on murine des-
min (referred to as TD31), using a phosphopeptide pS31 corre-
sponding to murine desmin phosphorylated at Ser31
(Supplementary Fig. 1A). As shown in Fig. 1E, TD31 reacted with
desmin incubated with Cdk1 but not with Aurora-B or Rho-kinase
or without any kinases (none). TD31 immunoreactivity toward
desmin phosphorylated by Cdk1 was completely diminished by
Fig. 2. Desmin phosphorylation by Cdk1 is required for efﬁcient separation of desmin intermediate ﬁlaments in mitosis. (A) Cells were stained with the indicated antibodies (green)
and DAPI (red; pseudo-color). (B) Type III IF-negative T24 cells were introduced with desmin WT or its mutant. After the transfection, cells were stained with anti-desmin antibody
(green) and propidium iodide (red). We showed representative images of post-mitotic cells with successful desmin-IF separation (Successful separation) or with IF-bridge, using T24
cells expressing desmin WT or its mutant at Cdk1 þ Aurora-B þ Rho-kinase phosphorylation sites (Triple sites), respectively (left). The percentage of post-mitotic cells with IF-
bridge was shown in the right graph. The desmin mutant at phosphorylation sites by Cdk1, Aurora-B þ Rho-kinase, or Cdk1 þ Aurora-B þ Rho-kinase is indicated as a Cdk1,
Double, or Triple, respectively (right). Data represents means ± SEM from three independent experiments (nS 200 each). **, P < 0.01, ***, P < 0.001; two-tailed unpaired t-test. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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ﬁrming the speciﬁcity of TD31.
Since IF component proteins are expressed in a cell-type-
speciﬁc manner, we examined which type of IF protein is
expressed in each cell line. As shown in Fig. 1F, desmin is expressed
in C2C12 (murine myoblastic) and BHK (baby hamster kidney
ﬁbroblastic) cells but not in U-251 (human glioblastoma) and HeLa
(human cervical carcinoma) cells, whereas vimentin is expressed in
the above 4 cell lines. In mitotic lysates of C2C12 and BHK cells,
TD31 speciﬁcally reacted with a band at 54 kDa corresponding to
the position of desmin, whereas this immunoreactivity was not
observed in their interphase cell lysates (Fig. 1G). TD31 immuno-
reactivity was observed in the entire cytoplasm of desmin-positive
(C2C12 or BHK) cells during early mitosis (from prometaphase to
metaphase; also see Fig. 2A) but not during interphase (Fig. 1H).
TD31 immunoreactivity was not detected in desmin-negative (HeLa
or U251) cells including early mitotic cells (arrowheads in Fig. 1H).
TD31 immunoreactivity was completely diminished by the pre-
incubation with the antigen phosphopeptide pS31 but not with
its non-phosphorylated version of peptide S31 (Supplementary
Fig. 1). All these data suggested that TD31 speciﬁcally recognizes
desmin phosphorylation at Ser31.Like GFAP and vimentin cases, mitotic desmin phosphorylations
are categorized into at least 2 groups (Fig. 2A). One is desmin
phosphorylation by Cdk1, which occurs in the entire cytoplasm
from prometaphase to metaphase (Figs. 1H and 2A). The other is
desmin phosphorylation by Aurora-B (see PD59 [anti-desmin-
phosphoSer59] immunostaining in Fig. 2A) and by Rho-kinase
(see PD75 [anti-desmin-phosphoThr75] immunostaining in
Fig. 2A; also see Fig. 1D and E), which occurs speciﬁcally at the
cleavage furrow from anaphase to telophase (during late mitosis).
These observations raised the question about the biological sig-
niﬁcance of each type of mitotic desmin phosphorylation. Since
type III IF proteins can form heteropolymeric IFs in combination
with other type III proteins [3], we chose type III-deﬁcient T24
(urinary bladder carcinoma) cells to evaluate the effects of exoge-
nous type III IF protein expression. The expression of desmin
mutated at Cdk1, Rho-kinase, and/or Aurora-B sites induced IF-
bridge (unusual long bridge-like IF structures) formed between
two daughter cells during cytokinesis, whereas the IF-bridge
phenotype was not observed when wild-type (WT) desmin was
exogenously expressed (Fig. 2B). Desmin mutations only at Cdk1
sites induced the IF-bridge phenotype at lower frequency than
Aurora-B and Rho-kinase (double) site mutations, but the addition
Fig. 3. Desmin-Ser31 phosphorylation in murine tissues at E15.5 (A) and P1 (B). We used 6-weeks-old mice as adult mice (C). To detect muscular cells, murine specimens were also
stained with anti-desmin (AeC). Scale bars represent 50 mm, except for ‘Tongue’ (in which a scale bar represents 500 mm). We calculated the average of proportion of TD31-positive
cells, using S 3 mice; data represent mean ± S.E.M. (n > 10 sections per each group; D).
Fig. 4. Desmin-Ser31 phosphorylation in rhabdomyosarcoma tissues. Tissue sections were obtained from two patients with rhabdomyosarcoma at different primary sites (Case 1,
upper arm of 14 yo male; Case 2, lower leg of 4 yo male).
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tions) signiﬁcantly increased the frequency of an IF-bridge
phenotype (Fig. 2B). These results suggested that Cdk1-induced
desmin phosphorylation also contributes to efﬁcient separation
desmin-IFs duringmitosis although its contribution may be slightly
lower than the contribution of cleavage-furrow-speciﬁc desmin
phosphorylation by Aurora-B and Rho-kinase.
We next examined whether desmin phosphorylation at Ser31
was detected in muscular cells in vivo. Desmin-Ser31 phosphory-
lation was observed at E15.5 in mitotic muscular cells (judged by
the staining with anti-desmin and nuclear morphology) of murine
tissues, such as heart, skeletal muscle, tongue, and tail (Fig. 3A and
Supplementary Fig. 2A). The frequency of desmin-Ser31 phos-
phorylation in these tissues was signiﬁcantly reduced at P1 (Fig. 3B,
D and Supplementary Fig. 2B) and then almost diminished at 6
weeks after the birth (Fig. 3C and D). We ﬁnally stained rhabdo-
myosarcoma tissues with TD31 because desmin-positive mitotic
cells were enriched in these tissues (Fig. 4). Desmin-Ser31 phos-
phorylation was detected in mitotic cells of human rhabdomyo-
sarcoma specimens from two patients (Fig. 4). All these results
suggested that desmin-Ser31 phosphorylation by Cdk1 generally
occurs in muscular cells during early mitosis in vivo.
In summary, desmin is phosphorylated by Cdk1 during mitosis
not only in desmin-positive cultured cells but also in tissue speci-
mens containing dividing muscular cells. In cultured cells, Cdk1-
induced desmin phosphorylation is required for efﬁcient separa-
tion of desmin-IFs during mitotic processes, together with
cleavage-furrow-speciﬁc desmin phosphorylation by Aurora-B and
Rho-kinase. Recently, we succeeded in the generation of knock-in
mice only expressing vimentin mutated at mitotic phosphoryla-
tion sites to Ala [32]. These mice exhibited several premature aging
phenotypes, such as lens cataract in the eye tissue [32] and
impaired wound healing in the skin tissue [33]. Based on our
ﬁndings in this study, we are now generating knock-in mice only
expressing desmin mutated at Cdk1, Aurora-B, and Rho-kinase
phosphorylation sites to Ala. The analyses of these phospho-
desmin-deﬁcient mice will provide new insights into the biolog-
ical signiﬁcance of desmin phosphorylation during mitosis for
organogenesis and tissue homeostasis.
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